Close X
Saturday, November 16, 2024
ADVT 
International

SII-Oxford developed world’s 2nd malaria vax gets WHO nod

Darpan News Desk IANS, 03 Oct, 2023 12:16 PM
  • SII-Oxford developed world’s 2nd malaria vax gets WHO nod

New Delhi, Oct 3 (IANS) The World Health Organisation (WHO) on Tuesday recommended the use of a low-cost and highly effective malaria vaccine developed by the Pune-based Serum Institute of India (SII) in collaboration with the University of Oxford in the UK.

The R21/Matrix-M malaria vaccine is the world’s second-ever WHO recommended vaccine for preventing malaria in children. In 2021,the RTS,S/AS01 vaccine became the first jab against the mosquito-borne disease to receive a WHO nod. 

The WHO’s independent advisory body, the Strategic Advisory Group of Experts (SAGE) and the Malaria Policy Advisory Group (MPAG), recommended use of the vaccine after reviewing its safety, quality and effectiveness standards last month.

Their recommendation was based on pre-clinical and clinical trial data which showed good safety and high efficacy in four countries, at sites with both seasonal and perennial malaria transmission. 

“As a malaria researcher, I used to dream of the day we would have a safe and effective vaccine against malaria. Now we have two,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General, in a statement. 

“Demand for the RTS,S vaccine far exceeds supply, so this second vaccine is a vital additional tool to protect more children faster, and to bring us closer to our vision of a malaria-free future,” he added.

The R21/Matrix-MTM malaria vaccine has been licensed for use in Ghana, Nigeria and Burkina Faso. In combination with public health measures such as the use of insecticide-treated bed nets, the new vaccine can help save and improve the lives of millions of children and their families.

In areas with highly seasonal malaria transmission (where malaria transmission is largely limited to 4 or 5 months per year), the R21 vaccine was shown to reduce symptomatic cases of malaria by 75 per cent during the 12 months following a 3-dose series. 

A fourth dose given a year after the third maintained efficacy. This high efficacy is similar to the efficacy demonstrated when RTS,S is given seasonally. 

The vaccine also showed good efficacy (66 per cent) during the 12 months following the first 3 doses. A fourth dose a year after the third maintained efficacy.  

Mathematical modelling estimates indicate the public health impact of the R21 vaccine is expected to be high in a wide range of malaria transmission settings, including low transmission settings. 

At prices of $2-$4 per dose, the cost-effectiveness of the R21 vaccine would be comparable with other recommended malaria interventions and other childhood vaccines. 

“The R21/Matrix-M malaria vaccine is easily deployable, cost effective and affordable, ready for distribution in areas where it is needed most, with the potential to save hundreds of thousands of lives a year,” said Professor Sir Adrian Hill, Director of The Jenner Institute, at Oxford. 

Notably, SII has already established production capacity for 100 million doses per annum, which will be doubled over the next two years. This scale of production is critical because vaccinating those at high risk of malaria will be important in stemming the spread of disease, as well as protecting the vaccinated.

“For far too long, malaria has threatened the lives of billions of people across the globe, disproportionately affecting the most vulnerable amongst us. This is why the WHO recommendation and approval of the R21/Matrix-M vaccine marks a huge milestone on our journey to combat this life-threatening disease,” said Adar Poonawalla, CEO of the Serum Institute of India, in a statement.

MORE International ARTICLES

Homicide Team Takes Over Langley, B.C., Shooting Probe After Death Of Victim

In a message posted to social media, the Integrated Homicide Investigation Team says the victim, who has not been named, died recently.    

Homicide Team Takes Over Langley, B.C., Shooting Probe After Death Of Victim

Infosys Co-founder Narayana Murthy’s Son-In-Law Rishi Sunak Is UK’s New Finance Minister

"The Queen has been graciously pleased to approve the appointment of Rt Hon Rishi Sunak as Chancellor of the Exchequer," Downing Street said in an official press release.  

Infosys Co-founder Narayana Murthy’s Son-In-Law Rishi Sunak Is UK’s New Finance Minister

UAE-Based Indian Sustains Burns While Trying To Save Wife

UAE-Based Indian Sustains Burns While Trying To Save Wife
A 32-year-old UAE-based Indian man sustained severe burn injuries while he tried to save his wife from a fire at their apartment in Umm Al Quwain, here, police said on Wednesday.

UAE-Based Indian Sustains Burns While Trying To Save Wife

Pakistan Court Sentences Mumbai Attack Mastermind Hafiz Saeed To 11 Years In Jail In Terror Financing Cases

Saeed, a UN designated terrorist whom the US has placed a $10 million bounty on, was arrested on July 17 in the terror financing cases. He is lodged at the Lahore’s Kot Lakhpat jail in high security.  

Pakistan Court Sentences Mumbai Attack Mastermind Hafiz Saeed To 11 Years In Jail In Terror Financing Cases

Sacred Native American Burial Sites Blown Up For US Border Wall

Native American burial sites in Arizona have been blown up by construction crews building the US-Mexico border wall, according to lawmakers and tribal leaders.

Sacred Native American Burial Sites Blown Up For US Border Wall

US President Donald Trump And First Lady Melania Trump To Visit India February 24-25

US President Donald Trump and First Lady Melania Trump will visit India from February 24-25, during which they will also travel to Prime Minister Narendra Modis home state.  

US President Donald Trump And First Lady Melania Trump To Visit India February 24-25